EE9700306A - Helicobacter pylori antigeenid ja vaktsiinisegud - Google Patents

Helicobacter pylori antigeenid ja vaktsiinisegud

Info

Publication number
EE9700306A
EE9700306A EE9700306A EE9700306A EE9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A EE 9700306 A EE9700306 A EE 9700306A
Authority
EE
Estonia
Prior art keywords
helicobacter pylori
pylori antigens
vaccine mixtures
vaccine
mixtures
Prior art date
Application number
EE9700306A
Other languages
English (en)
Inventor
B�lin Ingrid
Svennerholm Ann-Mari
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700306A publication Critical patent/EE9700306A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9700306A 1995-06-01 1996-06-03 Helicobacter pylori antigeenid ja vaktsiinisegud EE9700306A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
EE9700306A true EE9700306A (et) 1998-06-15

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700306A EE9700306A (et) 1995-06-01 1996-06-03 Helicobacter pylori antigeenid ja vaktsiinisegud

Country Status (22)

Country Link
US (2) US6025164A (et)
EP (1) EP0828757A1 (et)
JP (1) JP3380559B2 (et)
KR (1) KR19990022131A (et)
CN (1) CN1191544A (et)
AR (1) AR003125A1 (et)
BR (1) BR9608627A (et)
CA (1) CA2222797A1 (et)
CZ (1) CZ357397A3 (et)
EE (1) EE9700306A (et)
HU (1) HUP9901546A3 (et)
IL (1) IL122340A0 (et)
IS (1) IS4615A (et)
MY (1) MY119003A (et)
NO (1) NO975490L (et)
NZ (1) NZ303356A (et)
PL (1) PL323741A1 (et)
RU (1) RU2195463C2 (et)
SK (1) SK155297A3 (et)
TR (1) TR199701471T1 (et)
TW (1) TW570925B (et)
WO (1) WO1996038475A1 (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
JP3919812B2 (ja) * 1993-07-27 2007-05-30 シーエスエル、リミテッド Ｈ．ピロリ関連胃十二指腸疾患の治療
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
TR199701538T1 (xx) * 1995-06-07 1998-03-21 Astra Aktiebolag Helibakter pilor'un n�kleik asit ve amino asit sekanslar�.
EP0971734A4 (en) * 1997-03-26 2001-02-07 Avant Immunotherapeutics Inc CARBOHYDRATE ANTIGENS HAVING IMMUNOLOGICAL REACTIVITY WITH POLYCLONAL ANTISERUMS AGAINST H. PYLORI
BR9809426A (pt) * 1997-04-30 2000-06-13 Merieux Oravax Composição de vacina anti-helicobacter para uso pela via sistêmica subdiafragmática e método de imunização mucosal/parenteral combinado
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
US7393529B2 (en) * 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
EP1073745B1 (en) * 1998-04-30 2004-12-01 Chiron S.r.l. Immunization against and treatment for infection by h. pylori
AU3205000A (en) * 1999-02-19 2000-09-04 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
DE60124526D1 (de) * 2000-04-27 2006-12-28 Max Planck Gesellschaft Methode zur identifizierung von helicobacter antigenen
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
CA2535799A1 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
US20090269362A1 (en) * 2005-07-25 2009-10-29 Sant Andrea J Method for Controlling Immunodominance
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
CN108495650B (zh) 2015-12-14 2026-04-21 慕尼黑工业大学 幽门螺杆菌疫苗
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI914241A7 (fi) * 1989-03-09 1991-09-09 Praxis Biologics Inc Rokotteita ei-tyypitettävää Haemophilus influenzae-bakteereja vastaan
RU2009507C1 (ru) * 1991-06-28 1994-03-15 Российский государственный медицинский университет Способ диагностики пилорического геликобактериоза
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
IS4615A (is) 1997-11-17
CZ357397A3 (cs) 1998-05-13
SK155297A3 (en) 1998-08-05
NO975490L (no) 1998-01-07
AU6020596A (en) 1996-12-18
JPH11507210A (ja) 1999-06-29
BR9608627A (pt) 1999-06-15
IL122340A0 (en) 1998-04-05
MX9709194A (es) 1998-07-31
JP3380559B2 (ja) 2003-02-24
NZ303356A (en) 1999-05-28
PL323741A1 (en) 1998-04-14
US6025164A (en) 2000-02-15
AR003125A1 (es) 1998-07-08
NO975490D0 (no) 1997-11-28
TW570925B (en) 2004-01-11
AU703331B2 (en) 1999-03-25
RU2195463C2 (ru) 2002-12-27
WO1996038475A1 (en) 1996-12-05
MY119003A (en) 2005-03-31
US20020168726A1 (en) 2002-11-14
CN1191544A (zh) 1998-08-26
KR19990022131A (ko) 1999-03-25
TR199701471T1 (xx) 1998-02-21
EP0828757A1 (en) 1998-03-18
HUP9901546A2 (hu) 1999-08-30
HUP9901546A3 (en) 2003-07-28
CA2222797A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
IS4615A (is) Mótefnavakar Helicobacter pylori og bóluefnablöndur
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
FI963281L (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
AU3630093A (en) Helicobacter pylori proteins useful for vaccines and diagnostics
RU98100200A (ru) Антигены helicobacter pylori и вакцинные композиции
FI903721A7 (fi) Uusia antigeenejä ja niihin liittyviä menetelmiä
PT835663E (pt) Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios
EE04481B1 (et) Peptiididel ja adjuvantidel baseeruv farmatseutiline kompositsioon immuunmodulatsiooni jaoks
EE03778B1 (et) Vähivaktsiin ja selle valmistamismeetod
FI962844L (fi) T-soluantigeenireseptorin V-alueen proteiineja ja menetelmiä niiden valmistamiseksi
FI944052L (fi) Oraalinen rokote
DE69512853D1 (de) Bilderzeugungsverfahren und -Vorrichtungen
NO965023L (no) Maltitolblanding og fremstilling derav
IS5005A (is) Kjarnsýrur og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
EP0967993A4 (en) ANTI-COCAINE VACCINE
ATE253641T1 (de) Antigenische präparationen
DK0687728T3 (da) Reovirus stamme 2177 og vaccine indeholdende samme
FI971402A7 (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä s isältävien rokotteiden valmistamiseksi
FI973335L (fi) Helicobacter pylori-antigeeni
EP0770092A4 (en) PROTEIN D'-i (HELICOBARTER PYLORI) LINKED TO NICKEL
NO981407D0 (no) Protein fra Helicobacter pylori
IS5288A (is) Bóluefnablöndur sem innihalda FlgE pólýpeptíð Helicobacter pylori
HK1004135A (en) Helicobacter pylori antigens and vaccine compositions
FI944314L (fi) Vasta-aineen immunogeenisyyden selektiivinen muuttaminen
IL116541A0 (en) Helicobacter proteins and vaccines